The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. - Wikidata - awgldk - TriplyDB

The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.

The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.

http://www.wikidata.org/entity/Q30486489

about

Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine Role of mesenchymal cells in the natural history of ovarian cancer: a review The roles of mesenchymal stem cells in tumor inflammatory microenvironment The role of mesenchymal stem cells in cancer development Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation.The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance.Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis.The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway Oncolytic designer host defense peptide suppresses growth of human liposarcoma.Mesenchymal stem cells contribute to the chemoresistance of hepatocellular carcinoma cells in inflammatory environment by inducing autophagy.Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.Minocycline modulates NFκB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus in mesenchymal stromal/stem cells.The role of chemoattractant receptors in shaping the tumor microenvironment.Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile.Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications.Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis.Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells.Molecular biology for formyl peptide receptors in human diseases.Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition.Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro.Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists Helicobacter hepaticus--induced liver tumor promotion is associated with increased serum bile acid and a persistent microbial-induced immune response.Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer.Proteins and an inflammatory network expressed in colon tumors.Mesenchymal stem cells develop tumor tropism but do not accelerate breast cancer tumorigenesis in a somatic mouse breast cancer model.Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance.Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization.Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1 CecropinXJ, a silkworm antimicrobial peptide, induces cytoskeleton disruption in esophageal carcinoma cells.

P2860

Q24296488-DC0DA243-DAA2-4D62-859D-8585B6B5E632 Q24306866-1974A229-EDB1-4676-92E2-ACEFCC0C93EB Q24632756-B93EE52D-950F-4325-93E7-23C886C2E537 Q26823555-1A1497F3-B3FE-40DB-915C-28E541057FF1 Q26823759-84F66397-DA16-413B-AD59-678CB43DDC8B Q26823870-4F282C1A-6683-47FE-946B-F76D28BC8818 Q26853374-2BDFC4E6-4C3E-4EDA-8138-05536A5B9F6A Q27332133-D12F7EDD-389B-4E8F-9CE7-C4E51675E9B8 Q30424789-5A1020C9-D082-492C-9E43-4247A47C782A Q30490685-3064E7B7-2145-4BA6-88F7-E34C334B3406 Q30540212-4D26610A-C5A6-4849-BA24-A4292A964E1E Q30882988-516D5FC4-D843-42E1-BF75-73C405717093 Q30933550-9B40EB5F-2E38-4EA8-A9AD-786D60A989A3 Q33560685-83B84D6F-D6C7-4518-BB85-8B68BA89DD59 Q33570359-F907D94E-81B6-47A6-9F53-95D49B26A5C2 Q33584044-1CA9C85F-0181-4773-88ED-320A57D5718E Q33670905-6268C763-8AB9-41EF-B8B3-7059971BFFF0 Q33676440-2D417C71-A8CC-4FB1-93CF-5409634E23E5 Q33846843-8EB66518-E43D-4770-AA39-5FB2F0BA7BD9 Q33922806-97AB9892-BD0A-4EB0-9E0F-5D7DECBC306D Q33993124-3EB35690-0C31-48A7-AB70-101B7D3E8CF9 Q34042603-45A6EA24-3BDA-498F-B98D-3918AD07F648 Q34091593-2B76CF0B-DBF2-4A23-AF78-CB5CD47BFA03 Q34183523-357711CD-E894-4977-9412-A34A53B2F5CD Q34292996-372D13D9-CF06-4111-B459-442CB639F8CD Q34321571-D1AFCFC7-85A4-41E6-B930-8BEF2A31549E Q34327503-8BABF3D3-4D3F-40DA-81EE-E9C32B46598F Q34405052-BE0AAFEB-0F70-416F-82FA-AD8AEDC6811C Q34429538-5250FA05-0181-40CD-92CE-56B6A5D6C5CE Q34592889-12AABA55-68B3-4C4D-BCBD-1AB5E7F59CFD Q34645842-04D9AE17-F82F-4A0C-90CD-81DA533810AD Q34763420-2D34A618-13DE-44AA-8247-CE35BA2105BE Q34887528-E1436BB8-221A-4397-90B6-323296F63E40 Q34958339-DEA10F76-9ED5-4CAD-869E-C0C42D69CEA5 Q34998425-3A681912-744F-4A30-8913-0C590958E6AA Q35061366-FB46352C-5A5F-4C07-9C4D-B7948B32F9FB Q35107504-1C5EFAF6-B4AA-4C46-9BE7-96F03B56F00D Q35136732-4812821F-1685-43CC-860C-DB4535C4A63D Q35168237-74275849-6EAD-4223-A339-29C36AF8321F Q35224948-C7A93CD7-09D7-45BD-A4C8-F981D86D3709

P2860

The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.

http://www.wikidata.org/entity/Q30486489

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The pro-inflammatory peptide L ...... ent mesenchymal stromal cells.

@ast

The pro-inflammatory peptide L ...... ent mesenchymal stromal cells.

@en

type

label

The pro-inflammatory peptide L ...... ent mesenchymal stromal cells.

@ast

The pro-inflammatory peptide L ...... ent mesenchymal stromal cells.

@en

prefLabel

The pro-inflammatory peptide L ...... ent mesenchymal stromal cells.

@ast

The pro-inflammatory peptide L ...... ent mesenchymal stromal cells.

@en

P1433

Q30486489-BB56AE83-EFB1-4F0D-8910-966B0F7EAEE5

P1476

Q30486489-DB066AB9-28F6-4746-8F45-448C3CE8553C

P2093

Q30486489-01F3DEDF-B630-44DD-853C-7905E1E8CED7

Q30486489-01F85ADD-0E0B-4CA1-B35F-8A6A11A082F6

Q30486489-1329269D-4EA7-44E4-B618-D9E415986996

Q30486489-132C5F61-E3EF-4D4E-8203-C59A3C8F5D89

Q30486489-19093C8F-517F-447B-9848-FBAC78F0A2B2

Q30486489-33533E40-9040-40AC-B584-4F45692F018E

Q30486489-6927D892-3241-4CEF-B5D6-AC00AFA21611

Q30486489-DC0B3852-60D7-442B-B979-8580E21848C0

P2860

Q30486489-20B76E6B-5687-43CD-8F42-691FCEE85B5E

Q30486489-241B7B78-236A-418B-86D7-3BC7CDCE47CC

Q30486489-2A5CAE0C-C37C-405F-B9D1-508E2B2C7F92

Q30486489-2A9EB6BD-4652-41E4-B3C7-AE994F40D52A

Q30486489-2C94CE02-8EB5-4B28-A08C-0C869CC1342F

Q30486489-3494E324-D72F-4EAB-A2F6-2FC934A25A47

Q30486489-3808860D-3E5B-41FE-8F8D-548AF2C38147

Q30486489-42F44344-07CE-448F-B7DF-EEA5CF7D95DA

Q30486489-478FB4AB-665F-4ED3-B8B4-F0DBF29B5179

Q30486489-4C819D12-D4DF-4F75-B17E-0E717298AB8B

P304

Q30486489-7448B985-9E61-4927-979D-29813CD34FE9

P31

Q30486489-D308BF30-8C6F-4536-AB07-C30117EEA3DC

P356

Q30486489-7940905A-86DC-409E-8E86-B9C935CA72C5

P407

Q30486489-70246F3A-DB8C-4A52-969A-C94E050F58AB

P433

Q30486489-E4B968B2-CEE7-41FE-9EA9-55CD267D6B06

P478

Q30486489-706AEEFD-D437-4C98-B438-458A68AB4965

P50

Q30486489-4A326160-93D4-4078-B2AE-0924848B9212

Q30486489-4FD6C27B-243E-48CB-A338-482AE787FFF5

Q30486489-C8A5978B-38BA-427C-A620-E8A37E518485

P577

Q30486489-0DDB3AAA-4951-4E79-83C9-7B83249080DF

P5875

Q30486489-C7D46BF7-F4FB-4DCE-B383-495D344F286C

P698

Q30486489-B25BCB06-A36B-4254-AC20-C931F4178578

P921

Q30486489-F5784512-F4B8-431B-A996-7D0C34F238CD

P932

Q30486489-7268756D-7D42-4E87-846D-90AD080C3A26

P356

PNAS.0900244106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

The pro-inflammatory peptide L ...... tent mesenchymal stromal cells

@en

P2093

Aline B Scandurro

http://www.w3.org/2001/XMLSchema#string

Frank C Marini

http://www.w3.org/2001/XMLSchema#string

Heather L LaMarca

http://www.w3.org/2001/XMLSchema#string

Keri Watson

http://www.w3.org/2001/XMLSchema#string

Kerstin Honer zu Bentrup

http://www.w3.org/2001/XMLSchema#string

Kevin J Zwezdaryk

http://www.w3.org/2001/XMLSchema#string

Sarah L Henkle

http://www.w3.org/2001/XMLSchema#string

Suzanne L Tomchuck

http://www.w3.org/2001/XMLSchema#string

P2860

Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina

FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations

Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts

hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules

Mesenchymal stem cells in health and disease

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

P304

3806-3811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0900244106

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Seth B. Coffelt

Jennifer L Dembinski

Elizabeth Danka

P577

2009-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24031926

http://www.w3.org/2001/XMLSchema#string

P698

19234121

http://www.w3.org/2001/XMLSchema#string

P921

P932

2656161

http://www.w3.org/2001/XMLSchema#string